Literature DB >> 1661592

Evidence for a reverse transcription intermediate for a marked line transposon in tumoral rat cells.

E Segal-Bendirdjian1, T Heidmann.   

Abstract

We have marked a "reconstituted" LINE element from rat with an intron-containing indicator gene, to test for its RNA-mediated transposition in tumoral rat cells in culture. Three cloned LINE promoter-containing fragments were tested by a transient transfection assay using a LacZ reporter gene, and the promoter with maximum expression was substituted--in an homologous manner--to the 5' domain of a close to full-length genomic LINE. The resulting marked LINE was stably introduced by transfection into tumoral rat cells. PCR amplification of the DNA from several transfected clones, using primers bracketting the intronic domain of the indicator gene, yielded fragments with a reduced size: their DNA sequencing, in four cases out of four, demonstrated splicing out of the intron as expected for the passage of the marked LINE through an RNA intermediate and its reverse transcription. Fractionation of cellular DNA by the Hirt procedure indicated that reverse transcribed copies are present in the "extrachromosomal" fraction. Their abundance is close to 1 copy per 10(4) cells. These results strongly suggest that rat LINEs transpose through an RNA intermediate and its reverse transcription, as previously demonstrated for the Drosophila LINE I element and, further, that reverse transcription might take place prior to integration, resulting in extrachromosomal DNA molecules as preintegrative transposition intermediates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661592     DOI: 10.1016/0006-291x(91)91270-m

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  A genetically tagged, defective I element can be complemented by actively transposing I factors in the germline of I-R dysgenic females in Drosophila melanogaster.

Authors:  M C Chaboissier; C Bornecque; I Busseau; A Bucheton
Journal:  Mol Gen Genet       Date:  1995-08-30

2.  Transnuclear retrotransposition of the Tad element of Neurospora.

Authors:  J A Kinsey
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

3.  Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells.

Authors:  S L Martin; D Branciforte
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 4.  I factors in Drosophila melanogaster: transposition under control.

Authors:  I Busseau; M C Chaboissier; A Pélisson; A Bucheton
Journal:  Genetica       Date:  1994       Impact factor: 1.082

5.  The full-length transcript of the I factor, a LINE element of Drosophila melanogaster, is a potential bicistronic RNA messenger.

Authors:  K Bouhidel; C Terzian; H Pinon
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

6.  Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription.

Authors:  O Dhellin; J Maestre; T Heidmann
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

7.  Retrotransposition of a marked Drosophila line-like I element in cells in culture.

Authors:  S Jensen; L Cavarec; O Dhellin; T Heidmann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

8.  Germ-line expression of the I factor, a functional LINE from the fruit fly Drosophila melanogaster, is positively regulated by reactivity, a peculiar cellular state.

Authors:  P Lachaume; H Pinon
Journal:  Mol Gen Genet       Date:  1993-08

9.  The Doc transposable element in Drosophila melanogaster and Drosophila simulans: genomic distribution and transcription.

Authors:  C Vaury; M C Chaboissier; M E Drake; O Lajoinie; B Dastugue; A Pélisson
Journal:  Genetica       Date:  1994       Impact factor: 1.082

10.  mRNA retroposition in human cells: processed pseudogene formation.

Authors:  J Maestre; T Tchénio; O Dhellin; T Heidmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.